Lyrica (Pregabalin) Administered As An Add-On Therapy For Partial Seizures (LEADER) An Open-Label, Multicenter Add-On Therapy Trial.

Trial Profile

Lyrica (Pregabalin) Administered As An Add-On Therapy For Partial Seizures (LEADER) An Open-Label, Multicenter Add-On Therapy Trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Sep 2009

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Acronyms LEADER
  • Sponsors Pfizer
  • Most Recent Events

    • 14 Jul 2009 Actual patient number (98) added as reported by ClinicalTrials.gov.
    • 22 Sep 2008 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
    • 03 Jan 2008 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top